Gerhard Mueller

Axxima Pharmaceuticals AG provided drug discovery and development services. It was a drug discovery company in the field of kinase inhibition. It specialized in kinase-based drug discovery aimed at treating certain forms of cancer. It had also focussed on on HIV, Hepatitis C, tuberculosis and one particular herpes virus infections. The company was headquartered in Munich, Germany.

Polyneuron Pharmaceuticals AG develops drugs for the treatment of autoimmune disorders. It develops drugs for the treatment of anti-MAG neuropathy disease and multifocal motor neuropathy disease. The firm also develops antibody-catch, a platform technology that enables the development of drugs for highly specific interception of autoimmune disease antibodies and focuses on autoimmune diseases of the peripheral nervous system that involve autoantibodies against carbohydrate epitopes. The company was founded by Andreas J. Steck, Beat Ernst, Pascal Hänggi and Ruben Herrendorffin in 2014 and is headquartered in Basel, Switzerland.

M.M. Warburg & Co. KGaA (MM Warburg & Co. PB) is the investment advisory subsidiary of M.M. Warburg & Co. Gruppe KGaA in Germany. Established in 1798, M.M.Warburg & Co. is one of the largest private banks in Germany. All their capital is held by private individuals, while the Bank is managed by its co-owners. Located in Hamburg, Frankfurt and Cologne with subsidiary private banks in Berlin, Braunschweig, Bremen, Hanover, Luxembourg and Zurich, Switzerland, MM Warburg & Co. PB is a universal bank which offers a comprehensive range of services and products including financial planning, asset management, securities advice, advice on alternative investments and advice on inheritance planning and foundations.